These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 36919894)
1. A Case of Argatroban Refractory Heparin Induced Thrombocytopenia and Thrombosis. Seiler JA; Durrani AK; Ahmeti M Am Surg; 2023 Aug; 89(8):3574-3575. PubMed ID: 36919894 [TBL] [Abstract][Full Text] [Related]
2. Reducing harm associated with anticoagulation: practical considerations of argatroban therapy in heparin-induced thrombocytopenia. Hursting MJ; Soffer J Drug Saf; 2009; 32(3):203-18. PubMed ID: 19338378 [TBL] [Abstract][Full Text] [Related]
3. Intravenous warfarin and heparin-induced thrombocytopenia: making the diagnosis, management, modern monitoring, and multidisciplinary care. Burger CF; Schlesinger JJ Ann Pharmacother; 2014 Feb; 48(2):286-91. PubMed ID: 24259642 [TBL] [Abstract][Full Text] [Related]
5. Argatroban anticoagulation in patients with heparin-induced thrombocytopenia. Lewis BE; Wallis DE; Leya F; Hursting MJ; Kelton JG; Arch Intern Med; 2003 Aug 11-25; 163(15):1849-56. PubMed ID: 12912723 [TBL] [Abstract][Full Text] [Related]
6. Argatroban: a review of its use in the management of heparin-induced thrombocytopenia. Dhillon S Am J Cardiovasc Drugs; 2009; 9(4):261-82. PubMed ID: 19655821 [TBL] [Abstract][Full Text] [Related]
7. High-dose argatroban for treatment of heparin-induced thrombocytopenia with thrombosis: a case report and review of laboratory considerations. Hellwig TR; Peitz GJ; Gulseth MP Am J Health Syst Pharm; 2012 Mar; 69(6):490-5. PubMed ID: 22382479 [TBL] [Abstract][Full Text] [Related]
8. Management of heparin-induced thrombocytopenia: a critical comparison of lepirudin and argatroban. Warkentin TE Thromb Res; 2003 May; 110(2-3):73-82. PubMed ID: 12893020 [TBL] [Abstract][Full Text] [Related]
10. A randomized, open-label pilot study comparing desirudin and argatroban in patients with suspected heparin-induced thrombocytopenia with or without thrombosis: PREVENT-HIT Study. Boyce SW; Bandyk DF; Bartholomew JR; Frame JN; Rice L Am J Ther; 2011 Jan; 18(1):14-22. PubMed ID: 21079512 [TBL] [Abstract][Full Text] [Related]
11. Effects of argatroban therapy, demographic variables, and platelet count on thrombotic risks in heparin-induced thrombocytopenia. Lewis BE; Wallis DE; Hursting MJ; Levine RL; Leya F Chest; 2006 Jun; 129(6):1407-16. PubMed ID: 16778256 [TBL] [Abstract][Full Text] [Related]
12. Argatroban versus heparin in patients without heparin-induced thrombocytopenia during venovenous extracorporeal membrane oxygenation: a propensity-score matched study. Fisser C; Winkler M; Malfertheiner MV; Philipp A; Foltan M; Lunz D; Zeman F; Maier LS; Lubnow M; Müller T Crit Care; 2021 Apr; 25(1):160. PubMed ID: 33910609 [TBL] [Abstract][Full Text] [Related]
13. Emerging Role of Direct Oral Anticoagulants in the Management of Heparin-Induced Thrombocytopenia. Tran PN; Tran MH Clin Appl Thromb Hemost; 2018 Mar; 24(2):201-209. PubMed ID: 28301915 [TBL] [Abstract][Full Text] [Related]
17. Anticoagulation with Novastan (argatroban) in patients with heparin-induced thrombocytopenia and heparin-induced thrombocytopenia and thrombosis syndrome. Lewis BE; Walenga JM; Wallis DE Semin Thromb Hemost; 1997; 23(2):197-202. PubMed ID: 9200347 [TBL] [Abstract][Full Text] [Related]
18. Argatroban dose reductions for suspected heparin-induced thrombocytopenia complicated by child-pugh class C liver disease. Yarbrough PM; Varedi A; Walker A; Rondina MT Ann Pharmacother; 2012 Nov; 46(11):e30. PubMed ID: 23073302 [TBL] [Abstract][Full Text] [Related]